Received Oct 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DF | DENGUE TETRAVALENT (DENGVAXIA) | SANOFI PASTEUR | 1 | — | IM |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | — | IM / RA |
Background Patient received the Covid- 19 immunization yesterday morning and Flu shot in clinic today. Patient given flu shot this morning at 10:00 am and symptoms started around 11:00 am Assessment: Patient was out all morning shopping and symptoms hit her out of nowhere Patient started shaking violently, was cold, her jaw locked up and had a minor headache. Patients husband called 911 and was examined by EMS, and advised to follow-up with PCP. -Reports symptoms subsided by the time the paramedics were done talking to her. Episode occurred for approximately 30 minutes -Patients husband denies symptoms now. Patient is currently resting. -Patient has not had previous reactions to vaccines. Denies fever, shortness of breath, cough, runny nose, sore throat.
Benign essential hypertension 10/12/2016 SBO (small bowel obstruction) (H) 4/12/2017 PAD (peripheral artery disease) 6/19/2017 Bilateral low back pain without sciatica, unspecified chronicity 12/19/2017 Hyperlipidemia LDL goal <70 1/8/2019 Post-nasal drip 12/17/2019 Pancreatic cyst 8/11/2021 Overview IPMN stable, no further screening needed per GI. Cerebrovascular accident (CVA) due to thrombosis of right anterior cerebral artery (H) 8/27/2021 Overview Small multiple infarct of the Rt parietal and frontal (watershed distribution). CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min 7/6/2023 Hx of hernia repair 7/17/2024 Type 2 diabetes mellitus with kidney complication, without long-term current use of insulin (H)
Aspirin 81 mg, Atorvastatin 40 mg, Hydrochlorothiazide 25 mg, spironolactone 25 mg.
ACE inhibitors, sorbitan trioleate, sulfonylureas, and vancomycin.